Experimental drug fails to save doctor with Ebola
Print Edition
A LIBERIAN doctor treated with the experimental American anti-Ebola serum ZMapp has died, the West African nation said yesterday.
Abraham Borbor had been improving but died on Sunday night, said Liberian Information Minister Lewis Brown.
“He was showing signs of progress but he finally died. The government regrets this loss and extends its condolences to the bereaved family,” Brown said.
Two other health workers receiving the serum are still in treatment, said the minister, adding that there were “signs of hope.”
Last Thursday, the World Health Organization said there had been a “significant improvement” in the condition of a doctor and nurse being treated with ZMapp in Liberia and that another doctor was getting better but was still in a serious condition.
Liberia took delivery of ZMapp on August 13 from the United States, which gave the serum to two US citizens who were declared cured last week.
The Americans were infected in Liberia along with a Spanish priest who died on August 12, despite also receiving ZMapp.
The very small available stocks of ZMapp, which has never been through clinical trials on humans, have now been used up, according to the lab that produces it.
The WHO has been discussing the use of unapproved drugs as a way of getting a handle on an outbreak in Africa that has already cost more than 1,400 lives.
A panel of experts earlier this month determined it was “ethical” to provide experimental treatments.
There is currently no available cure or vaccine for Ebola, but several drugs are under development.
Tokyo says it is ready to offer an experimental Japanese drug. Avigan was approved as an anti-influenza drug in Japan in March and is currently in clinical tests in the US.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
